Matthew Leming, Ph.D., and Hyungsoon Im, Ph.D. of the Center for Systems Biology at Massachusetts General Hospital, are the ...

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming ...

In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...

Dr Umesh T explains how artificial intelligence is reshaping neurological diagnosis and care, from imaging interpretation to ...

Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) are essential tools for diagnosing brain diseases. However, PET image acquisition is typically associated with high costs and ...

A significant number of people lose their lives to multiple sclerosis each year, and many of these victims come from rural areas. However, the technology for early sclerosis diagnosis is not as ...

For imaging, the nanobeacons stably retained the positron emitter 89-zirconium and the MRI contrast agent gadolinium, without the need of a chelator. In addition to using them for PET imaging, the 89 ...

United Imaging Highlights Breakthrough PET/CT Technologies at SNMMI 2025 United Imaging Highlights Breakthrough PET/CT Technologies at SNMMI 2025 PR Newswire NEW ORLEANS, June 26, 2025 With ...

Positron emission tomography (PET) is a widely used in vivo imaging technology ideal to investigate receptors, ion channels, or kinases, as well as processes in the human brain on a molecular level.

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and ...